| Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy N Fillmore, J Mori, GD Lopaschuk British journal of pharmacology 171 (8), 2080-2090, 2014 | 478 | 2014 |
| ACE2 deficiency worsens epicardial adipose tissue inflammation and cardiac dysfunction in response to diet-induced obesity VB Patel, J Mori, BA McLean, R Basu, SK Das, T Ramprasath, N Parajuli, ... Diabetes 65 (1), 85-95, 2016 | 272 | 2016 |
| Angiotensin 1–7 Ameliorates Diabetic Cardiomyopathy and Diastolic Dysfunction in db/db Mice by Reducing Lipotoxicity and Inflammation J Mori, VB Patel, O Abo Alrob, R Basu, T Altamimi, J DesAulniers, ... Circulation: Heart Failure 7 (2), 327-339, 2014 | 195 | 2014 |
| ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4 J Mori, OA Alrob, CS Wagg, RA Harris, GD Lopaschuk, GY Oudit American Journal of Physiology-Heart and Circulatory Physiology 304 (8 …, 2013 | 180 | 2013 |
| Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal … J Mori, R Basu, BA McLean, SK Das, L Zhang, VB Patel, CS Wagg, ... Circulation: Heart Failure 5 (4), 493-503, 2012 | 173 | 2012 |
| Angiotensin 1–7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity J Mori, VB Patel, T Ramprasath, OA Alrob, J DesAulniers, JW Scholey, ... American Journal of Physiology-Renal Physiology 306 (8), F812-F821, 2014 | 165 | 2014 |
| Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterload P Zhabyeyev, M Gandhi, J Mori, R Basu, Z Kassiri, A Clanachan, ... Cardiovascular research 97 (4), 676-685, 2013 | 161 | 2013 |
| Antioxidant and antiviral activities of plastoquinones from the brown alga Sargassum micracanthum, and a new chromene derivative converted from the plastoquinones M Iwashima, J Mori, X Ting, T Matsunaga, K Hayashi, D Shinoda, H Saito, ... Biological and Pharmaceutical Bulletin 28 (2), 374-377, 2005 | 150 | 2005 |
| A synthetic study on antiviral and antioxidative chromene derivative J Mori, M Iwashima, M Takeuchi, H Saito Chemical and pharmaceutical bulletin 54 (3), 391-396, 2006 | 120 | 2006 |
| Effect of fatty acids on human bone marrow mesenchymal stem cell energy metabolism and survival N Fillmore, A Huqi, JS Jaswal, J Mori, R Paulin, A Haromy, ... PloS one 10 (3), e0120257, 2015 | 89 | 2015 |
| New plastoquinones isolated from the brown alga, Sargassum micracanthum J Mori, M Iwashima, H Wakasugi, H Saito, T Matsunaga, M Ogasawara, ... Chemical and pharmaceutical bulletin 53 (9), 1159-1163, 2005 | 73 | 2005 |
| Impact of the renin–angiotensin system on cardiac energy metabolism in heart failure J Mori, L Zhang, GY Oudit, GD Lopaschuk Journal of molecular and cellular cardiology 63, 98-106, 2013 | 72 | 2013 |
| ACE2 exerts anti-obesity effect via stimulating brown adipose tissue and induction of browning in white adipose tissue Y Kawabe, J Mori, H Morimoto, M Yamaguchi, S Miyagaki, T Ota, Y Tsuma, ... American Journal of Physiology-Endocrinology and Metabolism 317 (6), E1140-E1149, 2019 | 67 | 2019 |
| Involvement of GSK-3β and DYRK1B in differentiation-inducing factor-3-induced phosphorylation of cyclin D1 in HeLa cells F Takahashi-Yanaga, J Mori, E Matsuzaki, Y Watanabe, M Hirata, Y Miwa, ... Journal of Biological Chemistry 281 (50), 38489-38497, 2006 | 62 | 2006 |
| Angiotensin 1–7 stimulates brown adipose tissue and reduces diet-induced obesity H Morimoto, J Mori, H Nakajima, Y Kawabe, Y Tsuma, S Fukuhara, ... American Journal of Physiology-Endocrinology and Metabolism 314 (2), E131-E138, 2018 | 55 | 2018 |
| Functional interaction between Oct-1 and retinoid X receptor T Kakizawa, T Miyamoto, K Ichikawa, A Kaneko, S Suzuki, M Hara, ... Journal of Biological Chemistry 274 (27), 19103-19108, 1999 | 52 | 1999 |
| Elevation of serum creatine kinase during treatment with antithyroid drugs in patients with hyperthyroidism due to Graves disease: a novel side effect of antithyroid drugs S Suzuki, K Ichikawa, M Nagai, M Mikoshiba, J Mori, A Kaneko, R Sekine, ... Archives of internal medicine 157 (6), 693-696, 1997 | 50 | 1997 |
| Erythropoietin (EPO) ameliorates obesity and glucose homeostasis by promoting thermogenesis and endocrine function of classical brown adipose tissue (BAT) in diet-induced obese … K Kodo, S Sugimoto, H Nakajima, J Mori, I Itoh, S Fukuhara, K Shigehara, ... PloS one 12 (3), e0173661, 2017 | 49 | 2017 |
| Malonyl CoA decarboxylase inhibition improves cardiac function post-myocardial infarction W Wang, L Zhang, PK Battiprolu, A Fukushima, K Nguyen, K Milner, ... JACC: Basic to Translational Science 4 (3), 385-400, 2019 | 48 | 2019 |
| SRD5B1 gene analysis needed for the accurate diagnosis of primary 3‐oxo‐Δ4‐steroid 5β‐reductase deficiency I Ueki, A Kimura, HL Chen, T Yorifuji, J Mori, S Itoh, K Maruyama, T Ishige, ... Journal of gastroenterology and hepatology 24 (5), 776-785, 2009 | 45 | 2009 |
